Kjeld Hermansen
Researcher Next ID · RN-038981
Researcher · Medicine
Charlottenlund, Denmark
- Works count
- 439
- Citation count
- 20,044
- H-index
- 66
- i10-index
- 241
Research interests
Publications
Evidence-based European recommendations for the dietary management of diabetes
Diabetologia · 2023 · https://doi.org/10.1007/s00125-023-05894-8
Prevention of Type 2 Diabetes by Lifestyle Changes: A Systematic Review and Meta-Analysis
Nutrients · 2019 · https://doi.org/10.3390/nu11112611
Impact of Diet-Modulated Butyrate Production on Intestinal Barrier Function and Inflammation
Nutrients · 2018 · https://doi.org/10.3390/nu10101499
3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial
The Lancet · 2017 · https://doi.org/10.1016/s0140-6736(17)30069-7
Effects of Arabinoxylan and Resistant Starch on Intestinal Microbiota and Short-Chain Fatty Acids in Subjects with Metabolic Syndrome: A Randomised Crossover Study
PLoS ONE · 2016 · https://doi.org/10.1371/journal.pone.0159223
Effects of an isocaloric healthy N ordic diet on insulin sensitivity, lipid profile and inflammation markers in metabolic syndrome – a randomized study ( SYSDIET )
Journal of Internal Medicine · 2013 · https://doi.org/10.1111/joim.12044
The role of reducing intakes of saturated fat in the prevention of cardiovascular disease: where does the evidence stand in 2010?
American Journal of Clinical Nutrition · 2011 · https://doi.org/10.3945/ajcn.110.004622
Weight loss with liraglutide, a once‐daily human glucagon‐like peptide‐1 analogue for type 2 diabetes treatment as monotherapy or added to metformin, is primarily as a result of a reduction in fat tissue
Diabetes Obesity and Metabolism · 2009 · https://doi.org/10.1111/j.1463-1326.2009.01158.x
Efficacy and Safety Comparison of Liraglutide, Glimepiride, and Placebo, All in Combination With Metformin, in Type 2 Diabetes
Diabetes Care · 2008 · https://doi.org/10.2337/dc08-1355
Efficacy and safety of the dipeptidyl peptidase‐4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin
Diabetes Obesity and Metabolism · 2007 · https://doi.org/10.1111/j.1463-1326.2007.00744.x
Bodyweight Changes Associated with Antihyperglycaemic Agents in Type 2 Diabetes Mellitus
Drug Safety · 2007 · https://doi.org/10.2165/00002018-200730120-00005
A 26-Week, Randomized, Parallel, Treat-to-Target Trial Comparing Insulin Detemir With NPH Insulin as Add-On Therapy to Oral Glucose-Lowering Drugs in Insulin-Naive People With Type 2 Diabetes
Diabetes Care · 2006 · https://doi.org/10.2337/dc05-1365
Effects of dietary saturated, monounsaturated, and n−3 fatty acids on blood pressure in healthy subjects
American Journal of Clinical Nutrition · 2006 · https://doi.org/10.1093/ajcn/83.2.221
Evidence-based nutritional approaches to the treatment and prevention of diabetes mellitus
Nutrition Metabolism and Cardiovascular Diseases · 2004 · https://doi.org/10.1016/s0939-4753(04)80028-0
Insulin analogues (insulin detemir and insulin aspart) versus traditional human insulins (NPH insulin and regular human insulin) in basal-bolus therapy for patients with Type 1 diabetes
Diabetologia · 2004 · https://doi.org/10.1007/s00125-004-1365-z
Antihyperglycemic and blood pressure-reducing effects of stevioside in the diabetic Goto-Kakizaki rat
Metabolism · 2003 · https://doi.org/10.1053/meta.2003.50058
Antihyperglycemic effects of stevioside in type 2 diabetic subjects
Metabolism · 2003 · https://doi.org/10.1016/j.metabol.2003.07.013
Differential effects of saturated and monounsaturated fats on postprandial lipemia and glucagon-like peptide 1 responses in patients with type 2 diabetes
American Journal of Clinical Nutrition · 2003 · https://doi.org/10.1093/ajcn/77.3.605
Effects of dietary saturated, monounsaturated and n-3 fatty acids on fasting lipoproteins, LDL size and post-prandial lipid metabolism in healthy subjects
Atherosclerosis · 2003 · https://doi.org/10.1016/s0021-9150(02)00424-0
Stevioside induces antihyperglycaemic, insulinotropic and glucagonostatic effects in vivo: studies in the diabetic Goto-Kakizaki (GK) rats
Phytomedicine · 2002 · https://doi.org/10.1078/0944-7113-00081
Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: The KANWU study
Diabetologia · 2001 · https://doi.org/10.1007/s001250051620
Beneficial Effects of a Soy-Based Dietary Supplement on Lipid Levels and Cardiovascular Risk Markers in Type 2 Diabetic Subjects
Diabetes Care · 2001 · https://doi.org/10.2337/diacare.24.2.228
Diet, blood pressure and hypertension
British Journal Of Nutrition · 2000 · https://doi.org/10.1017/s0007114500001045
Stevioside acts directly on pancreatic β cells to secrete insulin: Actions independent of cyclic adenosine monophosphate and adenosine triphosphate—sensitivie K+-channel activity
Metabolism · 2000 · https://doi.org/10.1016/s0026-0495(00)91325-8
Differential effects of saturated and monounsaturated fatty acids on postprandial lipemia and incretin responses in healthy subjects
American Journal of Clinical Nutrition · 1999 · https://doi.org/10.1093/ajcn/69.6.1135
Current projects
No projects listed.